BSX
Boston Scientific Corp Health Care Surgical & Medical Instruments & Apparatus S&P 500Russell 3000
$41.98Close
$73.3BMarket cap
$41.58 – $104.9852-week range
Late-januaryNext report · estimated
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 7 · weaker than 93% of stocks over 12 months
- Far from its high 60% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
60%
1wk
down 8.1%
price change
1mo
down 3.8%
price change
12-month return
down 58%
market up 11% ·
its own down 69%
F-score
8 / 9
Exceptional
Altman Z
3.27
Low risk
P/E
25.3×
price / earnings
PEG
0.45
P/E / EPS growth
P/B
3.0×
price / book
Earnings yield
up 4.4%
EBIT / enterprise value
Cheaper than
60%
of the market · cheap
Revenue growth
up 20%
year on year
EPS growth
up 15%
latest quarter · -84 pts
Sales growth
up 8%
latest quarter · -4 pts
ROE
up 13%
return on equity
Free cash margin
up 18%
$3.7B FCF
D/E
0.46
long-term debt / equity
Net debt / EBITDA
1.8×
Interest cover
10.4×EBIT / interest
Piotroski tests
- issued more shares
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- gross margin widened
- assets working harder
Trade setup
ATR%
3.6%
$1.50 a day · 2×ATR $38.97
RS
7 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
0.69
50 sessions
Implied move
—
no scheduled report
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 28, 2026
Results reaction
Oct 28, 2026-5% vs market2 sessions after results
Options
$3.9M40.6% IV · activity
Financials
- Gross 69%
- Net 14%
- Free cash 18%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9B | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |
| Gross margin | 65% | 69% | 69% | 69% | 69% | 69% |
| Operating income | -$80.0M | $1.2B | $1.6B | $2.3B | $2.6B | $3.6B |
| Net income | -$82.0M | $1.0B | $698.0M | $1.6B | $1.8B | $2.9B |
| Net margin | -1% | 9% | 6% | 11% | 11% | 14% |
| Earnings per share | -$0.06 | $0.73 | $0.48 | $1.09 | $1.24 | $1.94 |
| Free cash flow | $1.1B | $1.3B | $938.0M | $1.8B | $2.6B | $3.7B |
| Free cash margin | 11% | 11% | 7% | 13% | 16% | 18% |
| Cash | $1.7B | $1.9B | $928.0M | $865.0M | $414.0M | $2.0B |
| Long-term debt | $9.1B | $9.1B | $8.9B | $9.1B | $10.7B | $11.1B |
| Shareholders' equity | $15.3B | $16.6B | $17.6B | $19.3B | $21.8B | $24.2B |
| Shares outstanding | 1.68bn | 1.69bn | 1.70bn | 1.73bn | 1.74bn | 1.75bn |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $38 – $46 ±8.8% by Nov 27, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 40.6% priced · 33.3% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- About the same
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs less
Positioning
- Premium traded
- $3.9M calls $1.7M · puts $2.2M · latest session
- 1.36× -2.97 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +5.61k · puts +28.69k past week
For options traders: ATM IV 40.6% (-9.1% 1w) · 1m ÷ 3m IV 1.03 · 25Δ skew 0.0 pts · Net GEX -$4.3M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 3, 2026 | Quarterly ↗ | Jun 30, 2026 | 34d |
| May 1, 2026 | Quarterly ↗ | Mar 31, 2026 | 31d |
| Feb 17, 2026 | Annual ↗ | Dec 31, 2025 | 48d |
| Nov 3, 2025 | Quarterly ↗ | Sep 30, 2025 | 34d |
| Aug 1, 2025 | Quarterly ↗ | Jun 30, 2025 | 32d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 18, 2025 | Annual ↗ | Dec 31, 2024 | 49d |
| Nov 1, 2024 | Quarterly ↗ | Sep 30, 2024 | 32d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 1, 2024 | Quarterly ↗ | Mar 31, 2024 | 31d |
| Feb 20, 2024 | Annual ↗ | Dec 31, 2023 | 51d |
| Nov 1, 2023 | Quarterly ↗ | Sep 30, 2023 | 32d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 28, 2026 | Results ↗ |
| Oct 7, 2026 | Director or officer change · Other events ↗ |
| Sep 23, 2026 | Director or officer change ↗ |
| Sep 8, 2026 | Cybersecurity incident ↗ |
| Aug 26, 2026 | Other events ↗ |
| Jul 29, 2026 | Results ↗ |
| Jul 27, 2026 | Restructuring ↗ |
| May 18, 2026 | Other events ↗ |
| May 18, 2026 | Other events ↗ |
| May 5, 2026 | Charter or bylaws · Shareholder vote ↗ |
| Apr 22, 2026 | Results ↗ |
| Mar 30, 2026 | Other events ↗ |